Diagnostics

Dutch Startup Innovates with Rapid Field Test for Infectious Diseases

Dutch Startup Innovates with Rapid Field Test for Infectious Diseases

Spotlight Diagnostics' new test kit offers a portable solution for detecting infectious diseases like malaria and Chlamydia, addressing the urgent need for accessible diagnostics amid rising disease prevalence due to climate change.

July 11, 2025
Intelligent Bio Solutions Inc. to Showcase Fingerprint Sweat PK Study at ADLM 2025 Clinical Lab Expo

Intelligent Bio Solutions Inc. to Showcase Fingerprint Sweat PK Study at ADLM 2025 Clinical Lab Expo

Intelligent Bio Solutions Inc. will present its pharmacokinetic study data at the ADLM 2025 Clinical Lab Expo, highlighting the reliability of fingerprint sweat as a non-invasive diagnostic tool for drug screening.

July 10, 2025
Hone Health's Diagnostic-First Approach Revolutionizes Preventative Care

Hone Health's Diagnostic-First Approach Revolutionizes Preventative Care

Hone Health, under CEO Saad Alam, is transforming preventative care by focusing on early diagnostics and personalized health optimization to extend healthspan.

July 8, 2025
MS Tech Secures $1.2M R&D Grant for Early Disease Detection Biosensors

MS Tech Secures $1.2M R&D Grant for Early Disease Detection Biosensors

MS Tech Ltd. has been awarded a $1.2M R&D grant by the Israel Innovation Authority to advance its innovative biosensor technology for early disease screening and biomarkers diagnostics, marking a significant step forward in point-of-care diagnostics.

July 2, 2025
Growing Public Interest in Mitochondrial Function Testing Highlights Advances in Health and Longevity

Growing Public Interest in Mitochondrial Function Testing Highlights Advances in Health and Longevity

The increasing public interest in mitochondrial health testing underscores significant advancements in addressing mitochondrial dysfunction and its implications for overall wellness and longevity.

June 26, 2025
Axim Biotechnologies Seeks FDA CLIA Waiver for Lactoferrin Diagnostic Test

Axim Biotechnologies Seeks FDA CLIA Waiver for Lactoferrin Diagnostic Test

Axim Biotechnologies has taken a significant step towards broadening access to its Lactoferrin diagnostic test by filing a Pre-Submission with the FDA for a CLIA Waiver, aiming to facilitate easier diagnosis and monitoring of Aqueous Deficient Dry Eye Disease.

June 24, 2025
Study Highlights Delayed Cancer Diagnosis in Younger Populations

Study Highlights Delayed Cancer Diagnosis in Younger Populations

Research from the University of Nottingham shows younger individuals with certain cancers face longer diagnosis times, underscoring the need for improved detection and treatment strategies.

June 4, 2025
Frame and Labcorp Partner to Revolutionize Fertility Care Access

Frame and Labcorp Partner to Revolutionize Fertility Care Access

Frame, a virtual fertility care platform, collaborates with Labcorp to address the critical gaps in fertility care, offering timely diagnostics and personalized support to individuals navigating their fertility journey.

June 3, 2025
Intelligent Bio Solutions Advances Non-Invasive Drug Testing Technology for U.S. Market

Intelligent Bio Solutions Advances Non-Invasive Drug Testing Technology for U.S. Market

Intelligent Bio Solutions is progressing toward FDA clearance for a groundbreaking fingerprint-based drug screening system with 94.1% accuracy, positioning the company for potential expansion across safety-critical industries in the United States.

May 23, 2025
Breakthrough Brain Tumor Test Promises Faster Diagnosis

Breakthrough Brain Tumor Test Promises Faster Diagnosis

A new diagnostic test for brain tumors could dramatically reduce the time needed for accurate diagnosis, potentially improving patient outcomes by enabling quicker treatment decisions.

May 23, 2025
Creative Biolabs Advances Exosome Research with Enhanced Platform Capabilities

Creative Biolabs Advances Exosome Research with Enhanced Platform Capabilities

Creative Biolabs has upgraded its Extracellular Vesicle platform, offering more precise exosome isolation, characterization, and RNA sequencing techniques that could accelerate disease research and diagnostic capabilities.

May 22, 2025
Viral TikTok Video Highlights Simple Hand Motion Test for Potential Brain Tumor Detection

Viral TikTok Video Highlights Simple Hand Motion Test for Potential Brain Tumor Detection

A social media trend reveals a 30-second hand test that could help individuals identify potential undiagnosed brain health issues, raising awareness about early symptom recognition.

May 14, 2025
Rapid Diagnostic Test Developed for Bacterial Meningitis

Rapid Diagnostic Test Developed for Bacterial Meningitis

Researchers at Amsterdam University Medical Center have created a new diagnostic test that can quickly and accurately detect bacterial meningitis by measuring protein levels in cerebrospinal fluid, potentially improving patient outcomes through faster diagnosis.

May 1, 2025
Fifty 1 Labs Launches BioSentry Division, Appoints New CEO to Advance Biohazard Detection Technology

Fifty 1 Labs Launches BioSentry Division, Appoints New CEO to Advance Biohazard Detection Technology

Fifty 1 Labs has appointed Michael Lawson as CEO and established a new BioSentry Division focused on developing advanced real-time sensor systems for detecting biological, chemical, and environmental threats across multiple sectors.

April 30, 2025
Fidget Spinner Transforms into Rapid Bacterial Detection Device

Fidget Spinner Transforms into Rapid Bacterial Detection Device

Researchers have developed a novel diagnostic tool using a fidget spinner with nanoplasmonic technology to detect bacterial species quickly and accurately. This innovative device could revolutionize point-of-care diagnostics, especially in resource-limited settings.

April 17, 2025
ProPhase Labs Sells Subsidiaries for $23.6M, Streamlines Business Focus

ProPhase Labs Sells Subsidiaries for $23.6M, Streamlines Business Focus

ProPhase Labs has completed the sale of its Pharmaloz subsidiaries to a private equity group, eliminating over $20 million in debt and positioning the company to concentrate on its core biotech and diagnostics businesses.

April 16, 2025
Breakthrough Blood Test Could Revolutionize Early Stroke Treatment

Breakthrough Blood Test Could Revolutionize Early Stroke Treatment

A new blood test measuring brain protein levels shows promise in quickly distinguishing between bleeding and clot-based strokes before patients reach the hospital, potentially transforming emergency stroke care and improving patient outcomes.

February 4, 2025
PreviousPage 2 of 2Next